B Vigneshwaran1, Akshat Wahal1, Sandeep Aggarwal2, Pratyusha Priyadarshini1, Hemanga Bhattacharjee1, Rajesh Khadgawat3, Rajkumar Yadav4. 1. Department of Surgical Disciplines, All India Institute of Medical Sciences (AIIMS), New Delhi, 110029, India. 2. Department of Surgical Disciplines, All India Institute of Medical Sciences (AIIMS), New Delhi, 110029, India. sandeep_aiims@yahoo.co.in. 3. Department of Endocrinology, All India Institute of Medical Sciences (AIIMS), New Delhi, 110029, India. 4. Department of Physiology, All India Institute of Medical Sciences (AIIMS), New Delhi, 110029, India.
Abstract
BACKGROUND: The study was conducted to evaluate the impact of laparoscopic sleeve gastrectomy (LSG) on type 2 diabetes mellitus (T2DM) in patients with a body mass index (BMI) of 30.0-35.0 kg/m2. Possible mechanisms, including alterations in gastric emptying time (GET), glucagon-like peptide 1 (GLP-1), ghrelin and leptin, were evaluated. METHODS: Twenty obese patients with T2DM and with a BMI of 30.0-35.0 kg/m2 underwent LSG during March 2012 to February 2015. Glycosylated haemoglobin (HbA1c), fasting plasma glucose (FPG) and GET were measured at baseline, 3 months, 6 months, 12 months and 24 months after surgery. Fasting and post-prandial levels of serum GLP-1, ghrelin and leptin were measured pre-operatively and after 3 and 6 months. RESULTS: The average duration of follow-up was 17.6 months, and 10 patients had completed 2 years of follow-up. After 2 years, the average BMI decreased from 33.4 ± 1.2 to 26.7 ± 1.8 kg/m2. The mean HbA1c decreased from 8.7 ± 1.6 to 6.7 ± 1.5 %, respectively. Ten patients achieved complete remission. Insulin could be stopped in all six patients who were on it pre-operatively. Meal-stimulated GLP-1 response and serum insulin at 30 min showed a significant increase following surgery. There was a significant decrease in GET. CONCLUSIONS: This prospective study confirms the positive impact of LSG on diabetic status of non-morbidly obese patients. The possible mechanisms include the rise in post-prandial GLP-1 level induced by accelerated gastric emptying, leading to an increase in insulin secretion. LSG also leads to decreased ghrelin and leptin levels which may have a role in improving glucose homeostasis after surgery.
BACKGROUND: The study was conducted to evaluate the impact of laparoscopic sleeve gastrectomy (LSG) on type 2 diabetes mellitus (T2DM) in patients with a body mass index (BMI) of 30.0-35.0 kg/m2. Possible mechanisms, including alterations in gastric emptying time (GET), glucagon-like peptide 1 (GLP-1), ghrelin and leptin, were evaluated. METHODS: Twenty obesepatients with T2DM and with a BMI of 30.0-35.0 kg/m2 underwent LSG during March 2012 to February 2015. Glycosylated haemoglobin (HbA1c), fasting plasma glucose (FPG) and GET were measured at baseline, 3 months, 6 months, 12 months and 24 months after surgery. Fasting and post-prandial levels of serum GLP-1, ghrelin and leptin were measured pre-operatively and after 3 and 6 months. RESULTS: The average duration of follow-up was 17.6 months, and 10 patients had completed 2 years of follow-up. After 2 years, the average BMI decreased from 33.4 ± 1.2 to 26.7 ± 1.8 kg/m2. The mean HbA1c decreased from 8.7 ± 1.6 to 6.7 ± 1.5 %, respectively. Ten patients achieved complete remission. Insulin could be stopped in all six patients who were on it pre-operatively. Meal-stimulated GLP-1 response and serum insulin at 30 min showed a significant increase following surgery. There was a significant decrease in GET. CONCLUSIONS: This prospective study confirms the positive impact of LSG on diabetic status of non-morbidly obesepatients. The possible mechanisms include the rise in post-prandial GLP-1 level induced by accelerated gastric emptying, leading to an increase in insulin secretion. LSG also leads to decreased ghrelin and leptin levels which may have a role in improving glucose homeostasis after surgery.
Authors: Deirdre G O'Donovan; Selena Doran; Christine Feinle-Bisset; Karen L Jones; James H Meyer; Judith M Wishart; Howard A Morris; Michael Horowitz Journal: J Clin Endocrinol Metab Date: 2004-07 Impact factor: 5.958
Authors: Bettina Woelnerhanssen; Ralph Peterli; Robert E Steinert; Thomas Peters; Yves Borbély; Christoph Beglinger Journal: Surg Obes Relat Dis Date: 2011-03-22 Impact factor: 4.734
Authors: W J Pories; M S Swanson; K G MacDonald; S B Long; P G Morris; B M Brown; H A Barakat; R A deRamon; G Israel; J M Dolezal Journal: Ann Surg Date: 1995-09 Impact factor: 12.969
Authors: Alan C Spector; Natasha Kapoor; Ruth K Price; M Yanina Pepino; M Barbara E Livingstone; Carel W Le Roux Journal: Chem Senses Date: 2019-03-11 Impact factor: 3.160
Authors: L Méndez-Giménez; S Becerril; S P Camões; I V da Silva; C Rodrigues; R Moncada; V Valentí; V Catalán; J Gómez-Ambrosi; J P Miranda; G Soveral; G Frühbeck; A Rodríguez Journal: Int J Obes (Lond) Date: 2017-06-06 Impact factor: 5.095
Authors: Eric J Vargas; Fateh Bazerbachi; Gerardo Calderon; Larry J Prokop; Victoria Gomez; M Hassan Murad; Andres Acosta; Michael Camilleri; Barham K Abu Dayyeh Journal: Clin Gastroenterol Hepatol Date: 2019-04-04 Impact factor: 11.382